Orlistat-Akrihin Capsules 60 mg # 42

Orlistat is a long-acting specific inhibitor of gastrointestinal lipases.

Acts in the lumen of the stomach and small intestine, forming a covalent bond with the active serine site of gastric and pancreatic lipases.

Indications for Use: Decrease in excess body weight (BMI? 28 kg / m2) when used in combination with a moderately hypocaloric, low-fat diet.

Clinical and pharmacological group

The drug is dispensed without a prescription.

ATX code

A08AB01

Dosage

60mg

Structure

active substance: orlistat - 60.00

auxiliary substances: microcrystalline cellulose - 28.55

sodium carboxymethyl starch - 20.75

colloidal silicon dioxide - 4.55

sodium lauryl sulfate - 1.15

capsule shell: hard gelatin capsule No. 3 (gelatin - 47.01 titanium dioxide (E171) - 0.96 indigo carmine (E132) - 0.03).

INN / Active ingredient

Orlistat

Storage conditions and periods

At a temperature not exceeding 25 degrees, in the original packaging.

Expiration date: 2 years

Specifications

Scope of the drug

Gastrointestinal tract

Release form

Capsules

Manufacturer country

Poland

Package quantity, pcs

42

Minimum age from

18 years

Way of introduction

Through the mouth

Vacation conditions

Without recipe

Brand name

Akrikhin

The amount of the dosage form in the primary package

14 pcs.

Primary packaging type

Blister

Type of consumer packaging

Pack of cardboard

Pharmaco-therapeutic group

Gastrointestinal lipase inhibitor

Anatomical and therapeutic characteristics

A08AB01 Orlistat

Dosage form

Capsules

Dosage (volume) of the substance in the preparation

orlistat - 60 mg

Expiration date in days

730

Package weight, g

45

Category

:

Nutrition for diabetics

,

Hypoglycemic drugs

,

Relief of hypoglycemia

,

Complications of diabetes

Mode of application

:

Inside, washed down with water, in a recommended dose of 60 mg before each main meal, with food or no later than an hour after a meal.

If a meal is skipped or the meal does not contain fat, orlistat can also be skipped.